Timely diagnosis and treatment of acute promyelocytic leukemia should be available to all von Schuh, Andre C

Volltext

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia von Kantarjian, Hagop, Stein, Anthony, Gökbuget, Nicola, Fielding, Adele K, Schuh, Andre C, Ribera, Josep-Maria, Wei, Andrew, Dombret, Hervé, Foà, Robin, Bassan, Renato, Arslan, Önder, Sanz, Miguel A, Bergeron, Julie, Demirkan, Fatih, Lech-Maranda, Ewa, Rambaldi, Alessandro, Thomas, Xavier, Horst, Heinz-August, Brüggemann, Monika, Klapper, Wolfram, Wood, Brent L, Fleishman, Alex, Nagorsen, Dirk, Holland, Christopher, Zimmerman, Zachary, Topp, Max S

Volltext

Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia von Montesinos, Pau, Recher, Christian, Vives, Susana, Zarzycka, Ewa, Wang, Jianxiang, Bertani, Giambattista, Heuser, Michael, Calado, Rodrigo T, Schuh, Andre C, Yeh, Su-Peng, Daigle, Scott R, Hui, Jianan, Pandya, Shuchi S, Gianolio, Diego A, de Botton, Stephane, Döhner, Hartmut

Volltext

A 17-gene stemness score for rapid determination of risk in acute leukaemia von Ng, Stanley W. K., Mitchell, Amanda, Kennedy, James A., Chen, Weihsu C., McLeod, Jessica, Ibrahimova, Narmin, Arruda, Andrea, Popescu, Andreea, Gupta, Vikas, Schimmer, Aaron D., Schuh, Andre C., Yee, Karen W., Bullinger, Lars, Herold, Tobias, Görlich, Dennis, Büchner, Thomas, Hiddemann, Wolfgang, Berdel, Wolfgang E., Wörmann, Bernhard, Cheok, Meyling, Preudhomme, Claude, Dombret, Hervé, Metzeler, Klaus, Buske, Christian, Löwenberg, Bob, Valk, Peter J. M., Zandstra, Peter W., Minden, Mark D., Dick, John E., Wang, Jean C. Y.

Volltext

Outcomes in Patients with Poor-Risk Cytogenetics with or without TP53 Mutations Treated with Venetoclax and Azacitidine von Pollyea, Daniel A, Pratz, Keith W, Wei, Andrew H, Pullarkat, Vinod, Jonas, Brian A, Recher, Christian, Babu, Sunil, Schuh, Andre C, Dail, Monique, Sun, Yan, Potluri, Jalaja, Chyla, Brenda, DiNardo, Courtney D

Volltext

Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine von Pratz, Keith W, Jonas, Brian A, Pullarkat, Vinod, Recher, Christian, Schuh, Andre C, Thirman, Michael J, Garcia, Jacqueline S, DiNardo, Courtney D, Vorobyev, Vladimir, Fracchiolla, Nicola S, Yeh, Su-Peng, Jang, Jun Ho, Ozcan, Muhit, Yamamoto, Kazuhito, Illes, Arpad, Zhou, Ying, Dail, Monique, Chyla, Brenda, Potluri, Jalaja, Döhner, Hartmut

Volltext

Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, p... von DiNardo, Courtney D, Schuh, Andre C, Stein, Eytan M, Montesinos, Pau, Wei, Andrew H, de Botton, Stéphane, Zeidan, Amer M, Fathi, Amir T, Kantarjian, Hagop M, Bennett, John M, Frattini, Mark G, Martin-Regueira, Patricia, Lersch, Frederik, Gong, Jing, Hasan, Maroof, Vyas, Paresh, Döhner, Hartmut

Volltext

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts von Dombret, Hervé, Seymour, John F., Butrym, Aleksandra, Wierzbowska, Agnieszka, Selleslag, Dominik, Jang, Jun Ho, Kumar, Rajat, Cavenagh, James, Schuh, Andre C., Candoni, Anna, Récher, Christian, Sandhu, Irwindeep, Bernal del Castillo, Teresa, Al-Ali, Haifa Kathrin, Martinelli, Giovanni, Falantes, Jose, Noppeney, Richard, Stone, Richard M., Minden, Mark D., McIntyre, Heidi, Songer, Steve, Lucy, Lela M., Beach, C.L., Döhner, Hartmut

Volltext

Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia von DiNardo, Courtney D, Stein, Anthony S, Stein, Eytan M, Fathi, Amir T, Frankfurt, Olga, Schuh, Andre C, Döhner, Hartmut, Martinelli, Giovanni, Patel, Prapti A, Raffoux, Emmanuel, Tan, Peter, Zeidan, Amer M, de Botton, Stéphane, Kantarjian, Hagop M, Stone, Richard M, Frattini, Mark G, Lersch, Frederik, Gong, Jing, Gianolio, Diego A, Zhang, Vickie, Franovic, Aleksandra, Fan, Bin, Goldwasser, Meredith, Daigle, Scott, Choe, Sung, Wu, Bin, Winkler, Thomas, Vyas, Paresh

Volltext

Oral azacitidine prolongs survival of patients with AML in remission independently of measurable residual disease status von Roboz, Gail J., Ravandi, Farhad, Wei, Andrew H., Dombret, Hervé, Thol, Felicitas, Voso, Maria Teresa, Schuh, Andre C., Porkka, Kimmo, La Torre, Ignazia, Skikne, Barry, Zhong, Jianhua, Beach, C.L., Risueño, Alberto, Menezes, Daniel L., Ossenkoppele, Gert, Döhner, Hartmut

Volltext

Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia von Shlush, Liran I., Zandi, Sasan, Mitchell, Amanda, Chen, Weihsu Claire, Brandwein, Joseph M., Gupta, Vikas, Kennedy, James A., Schimmer, Aaron D., Schuh, Andre C., Yee, Karen W., McLeod, Jessica L., Doedens, Monica, Medeiros, Jessie J. F., Marke, Rene, Kim, Hyeoung Joon, Lee, Kwon, McPherson, John D., Hudson, Thomas J., Pan-Leukemia Gene Panel Consortium, The HALT, Brown, Andrew M. K., Yousif, Fouad, Trinh, Quang M., Stein, Lincoln D., Minden, Mark D., Wang, Jean C. Y., Dick, John E.

Volltext

Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial von de Botton, Stéphane, Montesinos, Pau, Schuh, Andre C., Papayannidis, Cristina, Vyas, Paresh, Wei, Andrew H., Ommen, Hans, Semochkin, Sergey, Kim, Hee-Je, Larson, Richard A., Koprivnikar, Jaime, Frankfurt, Olga, Thol, Felicitas, Chromik, Jörg, Byrne, Jenny, Pigneux, Arnaud, Thomas, Xavier, Salamero, Olga, Vidriales, Maria Belen, Doronin, Vadim, Döhner, Hartmut, Fathi, Amir T., Laille, Eric, Yu, Xin, Hasan, Maroof, Martin-Regueira, Patricia, DiNardo, Courtney D.

Volltext

Time to repeal and replace response criteria for acute myeloid leukemia? von Bloomfield, Clara Derber, Estey, Elihu, Pleyer, Lisa, Schuh, Andre C., Stein, Eytan M., Tallman, Martin S., Wei, Andrew

Volltext

Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Aust... von Pleyer, Lisa, Döhner, Hartmut, Dombret, Hervé, Seymour, John F, Schuh, Andre C, Beach, C L, Swern, Arlene S, Burgstaller, Sonja, Stauder, Reinhard, Girschikofsky, Michael, Sill, Heinz, Schlick, Konstantin, Thaler, Josef, Halter, Britta, Machherndl Spandl, Sigrid, Zebisch, Armin, Pichler, Angelika, Pfeilstöcker, Michael, Autzinger, Eva M, Lang, Alois, Geissler, Klaus, Voskova, Daniela, Sperr, Wolfgang R, Hojas, Sabine, Rogulj, Inga M, Andel, Johannes, Greil, Richard

Volltext

Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in acute... von Murphy, Tracy, Zou, Jinfeng, Arruda, Andrea, Wang, Ting Ting, Zhao, Zhen, Zheng, Yangqiao, Gupta, Vikas, Maze, Dawn, McNamara, Caroline, Minden, Mark D, Schimmer, Aaron, Sibai, Hassan, Yee, Karen, Capo-Chichi, Jose-Mario, Stockley, Tracy, Schuh, Andre, Bratman, Scott V, Chan, Steven M

Volltext

Health-related quality of life in adults with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab von Topp, Max S., Zimmerman, Zachary, Cannell, Paul, Dombret, Hervé, Maertens, Johan, Stein, Anthony, Franklin, Janet, Tran, Qui, Cong, Ze, Schuh, Andre C.

Volltext

Azacitidine in adult patients with acute myeloid leukemia von Schuh, Andre C, Döhner, Hartmut, Pleyer, Lisa, Seymour, John F, Fenaux, Pierre, Dombret, Hervé

Volltext

Exploring clozapine use in severe psychiatric symptoms associated with autism spectrum disorder: A scoping review von da Rosa, André Luiz Schuh Teixeira, Bezerra, Olivia Sorato, Rohde, Luis Augusto, Graeff-Martins, Ana Soledade

Volltext

3+7 Combined Chemotherapy for Acute Myeloid Leukemia: Is It Time to Say Goodbye? von Tang, Kenny, Schuh, Andre C, Yee, Karen WL

Volltext

Survival outcomes with oral azacitidine maintenance in patients with acute myeloid leukemia in remission by receipt of initial chemotherapy: subgroup analyses from the phase III QU... von Wei, Andrew H, Roboz, Gail J, Dombret, Herve, Dohner, Hartmut, Schuh, Andre C, Montesinos, Pau, Selleslag, Dominik, Bondarenko, Sergey N, Prebet, Thomas, Lai, Yinzhi, Skikne, Barry, Beach, C L, Ravandi, Farhad

Volltext